FORWARD FEATURES CALENDAR

Deals

GI Partners has completed a dual-structured transaction comprising the close of an oversubscribed single-asset continuation vehicle and a strategic equity investment from its GI Data Infrastructure fund into Flexential, a US-based provider of data centre and hybrid IT solutions.
YFM Equity Partners (YFM) has invested in MurphyCobb & Associates (MCA), a London-headquartered advertising production consultancy with operations in 38 countries.
Bain Capital and Cinven are resuming IPO preparations for German pharmaceutical company Stada Arzneimittel, following a pause in sale discussions with CapVest Partners, according to a report by Bloomberg citing sources familiar with the matter.
Private equity giant Thoma Bravo has agreed to acquire Dayforce in a deal valued at $11.18bn ($12.3bn including debt), according to a report by Reuters citing a company statement issued by the human capital management software provider on Wednesday.
Asian healthcare-focused private equity firm Quadria Capital is exploring the sale of its minority stake in Indian topical pharmaceuticals company Encube Ethicals, according to a report by Bloomberg citing unnamed sources familiar with the matter.
YFM Equity Partners (YFM) has invested in MurphyCobb & Associates (MCA), a London-headquartered advertising production consultancy with operations in 38 countries.
Thompson Street Capital Partners (TSCP), a St Louis-based private equity firm, has sold its portfolio company, DDC Solutions, to Daikin Applied, a subsidiary of Japan-headquartered HVAC manufacturer Daikin Industries.
TPG has announced a strategic partnership with Vanara Capital, a newly launched investment management firm focused on growth-stage technology opportunities, according to a report by Bloomberg.
Continuation vehicles (CVs) are becoming a defining feature of private equity exit strategies, with implications that could fundamentally reshape the industry’s traditional buyout model, according to a report by Bloomberg citing new research from Schroders Capital, the private assets division of Schroders.
Bain Capital and Cinven are resuming IPO preparations for German pharmaceutical company Stada Arzneimittel, following a pause in sale discussions with CapVest Partners, according to a report by Bloomberg citing sources familiar with the matter.

Events

12 November, 2026 – 8:00 am

Directory Listings